We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
anti-Plasmodium falciparum HRPII Antibody (Mouse) - HRP Conjugated
A monoclonal antibody specific for Plasmodium falciparum Histidine-Rich Protein II (HRP2), used in malaria research and diagnostics. Suitable for detecting P. falciparum antigen in immunoassays such as ELISA and rapid diagnostic tests (RDTs).
| Antibody Type | Primary Antibody |
|---|---|
| Host | Mouse |
| Target Species | Parasite / Bacteria |
| Specificity/Target | Plasmodium falciparum HRP2 |
| Size | 0.5 |
| Clonality | Monoclonal |
| Type | HRP Conjugated |
| Origin | USA |
| Shelf Life | 1 year |
| Format | Liquid |
| Buffer | HEPES – saline with stabilizer |
| Preservative | 0.002% Thimerosal |
| Storage | 2-8C |
| Application | ELISA |
| Purity | Antigen Affinity Purified |
San Kyawt Khine, Poe Poe Aung, Nay Yi Yi Linn et al. Assessment of a Highly Sensitive Rapid Diagnostic Test for Reactive Case Detection of Malaria Infections in Myanmar, 15 May 2025, PREPRINT (Version 1) available at Research Square [https://doi.org/10.21203/rs.3.rs-6552550/v1]
Walunj SB, Dias MM, Kaur C, et al. High-Throughput Screening to Identify Inhibitors of Plasmodium falciparum Importin α. Cells. 2022;11(7):1201. Published 2022 Apr 2. doi:10.3390/cells11071201
Ghosh S, Aggarwal K, U VT, Nguyen T, Han J, Ahn CH. A new microchannel capillary flow assay (MCFA) platform with lyophilized chemiluminescence reagents for a smartphone-based POCT detecting malaria. Microsyst Nanoeng. 2020;6:5. Published 2020 Jan 27. doi:10.1038/s41378-019-0108-8
Hossainey MRH, Sazed SA, Nima MK, et al. Investigation of antimalarial activity and cytotoxicity profiling of a Bangladeshi plant Syzygium cymosum. J Infect Dev Ctries. 2020;14(8):924-928. Published 2020 Aug 31. doi:10.3855/jidc.12740
Safeukui I, Gomez ND, Adelani AA, et al. Malaria induces anemia through CD8+ T cell-dependent parasite clearance and erythrocyte removal in the spleen. mBio. 2015;6(1):e02493-14. Published 2015 Jan 20. doi:10.1128/mBio.02493-14
Tahita MC, Tinto H, Yarga S, et al. Ex vivo anti-malarial drug susceptibility of Plasmodium falciparum isolates from pregnant women in an area of highly seasonal transmission in Burkina Faso. Malar J. 2015;14:251. Published 2015 Jun 20. doi:10.1186/s12936-015-0769-1
Boechat N, Ferreira Mde L, Pinheiro LC, et al. New compounds hybrids 1h-1,2,3-triazole-quinoline against Plasmodium falciparum. Chem Biol Drug Des. 2014;84(3):325-332. doi:10.1111/cbdd.12321
Gomes A, Pérez B, Albuquerque I, et al. N-cinnamoylation of antimalarial classics: quinacrine analogues with decreased toxicity and dual-stage activity. ChemMedChem. 2014;9(2):305-310. doi:10.1002/cmdc.201300459
Mohd Abd Razak MR, Afzan A, Ali R, et al. Effect of selected local medicinal plants on the asexual blood stage of chloroquine resistant Plasmodium falciparum. BMC Complement Altern Med. 2014;14:492. Published 2014 Dec 15. doi:10.1186/1472-6882-14-492
Kariuki S, et al. Value of Plasmodium falciparum Histidine-Rich Protein 2 Level and Malaria Retinopathy in Distinguishing Cerebral Malaria From Other Acute Encephalopathies in Kenyan Children J Infect Dis. 2014 Feb 15; 209(4): 600–609.
Sauerzopf U, et al. In vitro growth of Plasmodium falciparum in neonatal blood Malaria Journal201413:436 DOI: 10.1186/1475-2875-13-436
Boechat N, Pinheiro LC, Silva TS, et al. New trifluoromethyl triazolopyrimidines as anti-Plasmodium falciparum agents. Molecules. 2012;17(7):8285-8302. Published 2012 Jul 10. doi:10.3390/molecules17078285
Noedl H, Krudsood S, Leowattana W, et al. In vitro antimalarial activity of azithromycin, artesunate, and quinine in combination and correlation with clinical outcome. Antimicrob Agents Chemother. 2007;51(2):651-656. doi:10.1128/AAC.01023-06
Noedl H, Bronnert J, Yingyuen K, Attlmayr B, Kollaritsch H, Fukuda M. Simple histidine-rich protein 2 double-site sandwich enzyme-linked immunosorbent assay for use in malaria drug sensitivity testing. Antimicrob Agents Chemother. 2005;49(8):3575-3577. doi:10.1128/AAC.49.8.3575-3577.2005

